Why the study?
Does proper management of cardiac disease and dialysis treatment prevent sudden cardiac death in dialysis patients?
Does proper management of cardiac disease and dialysis treatment prevent sudden cardiac death in dialysis patients?
Proper management of cardiac disease, utilization of ACE inhibitors and beta-blockers, and appropriate management of dialysate potassium are recommended to prevent sudden cardiac death in dialysis patients.
Answers are grounded in this paper and cite their sources.
Supports cardiac optimization in dialysis; leaves open need for RCTs to confirm sudden-death reduction.
Sudden death is a common and at times preventable cause of death in the dialysis population. Prevention of sudden death can be accomplished in the dialysis population by proper management of cardiac disease and attention to dialysis treatment. The proper usage of medications such as angiotensin‐converting enzyme inhibitors and beta‐blockers is likely to decrease the risk of sudden death, yet these medications are underutilized in the dialysis population. Appropriate management of dialysate potassium is also important. A systematic method should be developed in each dialysis center to identify risk factors for sudden death, institute appropriate treatment, and monitor outcomes.
No takes yet. Share an insight, caveat, or question.
Anthony J. Bleyer (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: